Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Operating Expenses | 7,531 | 8,323 | 8,554 | 6,328 | 7,169 |
| Operating Income | -7,531 | -8,323 | -8,554 | -6,328 | -7,169 |
| Interest Expense | -85 | 0 | 0 | 0 | -67 |
| Other Income | 150 | 45 | 390 | 103 | 764 |
| Pre-tax Income | -7,297 | -8,278 | -8,164 | -6,225 | -6,338 |
| Net Income Continuous | -7,297 | -8,278 | -8,164 | -6,225 | -6,338 |
| Minority Interests | -75 | -81 | -73 | -98 | -46 |
| Net Income | $-7,222 | $-8,198 | $-8,091 | $-6,127 | $-6,291 |
| EPS Basic Total Ops | -2.58 | -4.35 | 10.19 | -16.40 | -23.31 |
| EPS Basic Continuous Ops | -2.60 | -4.39 | 10.12 | -16.66 | -23.48 |
| EPS Diluted Total Ops | -2.58 | -4.35 | 10.19 | -16.40 | -23.31 |
| EPS Diluted Continuous Ops | -2.60 | -4.39 | 10.12 | -16.66 | -23.48 |
| EPS Diluted Before Non-Recurring Items | -2.58 | -4.35 | N/A | -16.40 | -23.30 |
| EBITDA(a) | $-7,505 | $-8,296 | $-8,528 | $-6,302 | $-7,143 |